Search Results 1071-1080 of 18183 for coronavirus
* Laboratory confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection at screening * History of malignancy in the last 5 years * ...
The purpose of this study is to focus on identifying genomic factors that are associated with COVID-19 infection and severity in Latinx individuals. The ...
Shah, M.B.B.S.. Infectious Disease Specialist. Rochester, MN. Areas of focus: Coronavirus disease 2019, Lyme disease, General infectious diseases, Sepsis ...
Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and ...
Has had clinically significant infection (eg, pneumonia, pyelonephritis, coronavirus disease 2019 [COVID-19]) within 30 days prior to first dose of study ...
An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20094084.
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). - As judged by the Investigator: any evidence of severe or uncontrolled systemic diseases, (eg ...
... Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center. Media contact: Sharon ...
Medical Professionals news and the latest information about Cancer.
Screening nasopharyngeal PCR test is positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Any acute, chronic, or unstable medical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.